Delivering on a vision of a digitally enabled future for viral vector manufacturing

Cell & Gene Therapy Insights 2024; 10(3), 283–288

DOI: 10.18609/cgti.2024.042

Published: 12 April
Sönke Brunswieck, Tania Chilima

Consultants Sönke Brunswieck and Tania Chilima share their thoughts on the need for a holistic approach to product and process development in the gene therapy space—an objective that can only be achieved by correctly harnessing the power of digital tools.